dr. matulonis discusses maintenance in ovarian cancer
Published 7 years ago • 268 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:47
dr. matulonis on the nova trial of niraparib maintenance therapy in ovarian cancer
-
2:16
dr. matulonis discusses mirvetuximab soravtansine plus pembrolizumab in ovarian cancer
-
1:44
dr. matulonis on the current treatment landscape in ovarian cancer
-
0:58
dr. matulonis on individualized dosing of niraparib in ovarian cancer
-
1:54
dr. matulonis on toxicities with olaparib for patients with ovarian cancer
-
2:20
dr. matulonis discusses niraparib/pembrolizumab combo in platinum-resistant ovarian cancer
-
1:25
dr. matulonis on final data from keynote-100 in recurrent ovarian cancer
-
1:06
dr. matulonis discusses rationale of quadra trial
-
0:49
dr. matulonis on cps as a potential biomarker in advanced recurrent ovarian cancer
-
3:10
overview of engot-ov16/nova of niraparib in ovarian cancer and why the results were not surprising
-
1:17
dr. matulonis on the use of immunotherapy in recurrent ovarian cancer
-
1:24
ursula matulonis explains the use of parp inhibitors for ovarian cancer
-
2:30
dr. matulonis on toxicities with parp inhibitors in ovarian cancer
-
0:54
dr. ursula matulonis on phase iii trials examining cediranib plus olaparib in ovarian cancer
-
1:15
dr. o’malley on the safety profile of mirvetuximab in ovarian cancer
-
1:39
dr. matulonis discusses qol data from gog-258 in endometrial cancer
-
6:57
niraparib maintenance for recurrent ovarian cancer
-
4:52
ovarian cancer decisions: treatment versus maintenance
-
3:28
managing ovarian cancer patients in the future